<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Project 2: Medicare Part D Opioid Prescribing Integrity Analytics - Seemab Analytics</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            color: #333;
        }

        nav {
            background: rgba(255, 255, 255, 0.98);
            padding: 1.2rem 0;
            position: fixed;
            width: 100%;
            top: 0;
            z-index: 1000;
            box-shadow: 0 2px 20px rgba(0,0,0,0.1);
        }

        nav .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 2rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .logo {
            font-size: 1.8rem;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea, #764ba2);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            text-decoration: none;
        }

        nav ul {
            list-style: none;
            display: flex;
            gap: 2.5rem;
        }

        nav a {
            text-decoration: none;
            color: #555;
            font-weight: 500;
            transition: color 0.3s;
        }

        nav a:hover {
            color: #667eea;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 7rem 2rem 3rem;
        }

        .content {
            background: white;
            border-radius: 20px;
            padding: 3rem;
            box-shadow: 0 20px 60px rgba(0, 0, 0, 0.1);
            margin-top: 2rem;
        }

        h1 {
            font-size: 2.8rem;
            margin-bottom: 1rem;
            color: #1a1a1a;
            line-height: 1.2;
        }

        .subtitle {
            font-size: 1.3rem;
            color: #666;
            margin-bottom: 3rem;
            line-height: 1.6;
        }

        .key-metrics {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1.5rem;
            margin-bottom: 3rem;
        }

        .metric-card {
            background: linear-gradient(135deg, #667eea, #764ba2);
            padding: 1.8rem;
            border-radius: 15px;
            color: white;
            box-shadow: 0 10px 25px rgba(102, 126, 234, 0.3);
            transition: transform 0.3s, box-shadow 0.3s;
        }

        .metric-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 35px rgba(102, 126, 234, 0.4);
        }

        .metric-value {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
        }

        .metric-label {
            font-size: 0.95rem;
            opacity: 0.95;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .section {
            margin-bottom: 3rem;
        }

        h2 {
            font-size: 2rem;
            margin-bottom: 1.5rem;
            color: #2d2d2d;
            border-bottom: 3px solid #667eea;
            padding-bottom: 0.5rem;
            display: inline-block;
        }

        h3 {
            font-size: 1.5rem;
            margin-bottom: 1rem;
            margin-top: 2rem;
            color: #444;
        }

        p {
            line-height: 1.8;
            color: #555;
            margin-bottom: 1.5rem;
            font-size: 1.05rem;
        }

        ul {
            margin-left: 2rem;
            margin-bottom: 1.5rem;
            line-height: 1.8;
        }

        li {
            margin-bottom: 0.8rem;
            color: #555;
        }

        .highlight-box {
            background: linear-gradient(135deg, rgba(102, 126, 234, 0.08), rgba(118, 75, 162, 0.08));
            border-left: 4px solid #667eea;
            padding: 1.5rem;
            border-radius: 10px;
            margin: 2rem 0;
        }

        .highlight-box p {
            margin-bottom: 0.5rem;
            color: #444;
            font-weight: 500;
        }

        .figure-container {
            background: #f8f9fa;
            padding: 2rem;
            border-radius: 15px;
            margin: 2rem 0;
            text-align: center;
        }

        .figure-container img {
            max-width: 100%;
            height: auto;
            border-radius: 10px;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
        }

        .figure-title {
            margin-top: 1rem;
            font-size: 0.95rem;
            color: #666;
            font-style: italic;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
            background: white;
            box-shadow: 0 5px 15px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th {
            background: linear-gradient(135deg, #667eea, #764ba2);
            color: white;
            padding: 1rem;
            text-align: left;
            font-weight: 600;
        }

        td {
            padding: 1rem;
            border-bottom: 1px solid #e8e8e8;
        }

        tr:last-child td {
            border-bottom: none;
        }

        tr:hover {
            background: #f8f9fa;
        }

        .tech-stack {
            display: flex;
            flex-wrap: wrap;
            gap: 1rem;
            margin: 1.5rem 0;
        }

        .tech-badge {
            background: linear-gradient(135deg, rgba(102, 126, 234, 0.15), rgba(118, 75, 162, 0.15));
            color: #667eea;
            padding: 0.6rem 1.2rem;
            border-radius: 20px;
            font-weight: 600;
            font-size: 0.9rem;
            border: 2px solid rgba(102, 126, 234, 0.3);
        }

        .stat-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }

        .stat-item {
            background: linear-gradient(135deg, rgba(102, 126, 234, 0.08), rgba(118, 75, 162, 0.08));
            padding: 1.5rem;
            border-radius: 12px;
            text-align: center;
            border: 2px solid rgba(102, 126, 234, 0.2);
        }

        .stat-number {
            font-size: 2.5rem;
            font-weight: 700;
            color: #667eea;
            margin-bottom: 0.5rem;
        }

        .stat-label {
            color: #666;
            font-size: 0.95rem;
            font-weight: 500;
        }

        .nav-buttons {
            display: flex;
            justify-content: space-between;
            margin-top: 3rem;
            padding-top: 2rem;
            border-top: 2px solid #e8e8e8;
        }

        .nav-btn {
            background: linear-gradient(135deg, #667eea, #764ba2);
            color: white;
            padding: 1rem 2rem;
            border-radius: 10px;
            text-decoration: none;
            font-weight: 600;
            transition: transform 0.3s, box-shadow 0.3s;
            box-shadow: 0 5px 15px rgba(102, 126, 234, 0.3);
        }

        .nav-btn:hover {
            transform: translateY(-3px);
            box-shadow: 0 8px 25px rgba(102, 126, 234, 0.4);
        }

        @media (max-width: 768px) {
            .container {
                padding: 6rem 1rem 2rem;
            }

            .content {
                padding: 2rem;
            }

            h1 {
                font-size: 2rem;
            }

            .subtitle {
                font-size: 1.1rem;
            }

            nav ul {
                flex-direction: column;
                gap: 1rem;
            }

            .nav-buttons {
                flex-direction: column;
                gap: 1rem;
            }
        }
    </style>
</head>
<body>
    <nav>
        <div class="container">
            <a href="index.html" class="logo">Seemab Analytics</a>
            <ul>
                <li><a href="index.html">Home</a></li>
                <li><a href="projects.html">Projects</a></li>
                <li><a href="about.html">About</a></li>
                <li><a href="contact.html">Contact</a></li>
            </ul>
        </div>
    </nav>

    <div class="container">
        <div class="content">
            <h1>Project 2: Medicare Part D Opioid Prescribing Integrity Analytics</h1>
            <p class="subtitle">Identifying High-Risk Patterns Through Machine Learning and Peer Benchmarking</p>

            <div class="key-metrics">
                <div class="metric-card">
                    <div class="metric-value">$1.22B</div>
                    <div class="metric-label">Excess Medicare Costs Identified</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">1.03M</div>
                    <div class="metric-label">Prescribers Analyzed</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">51,660</div>
                    <div class="metric-label">High-Risk Prescribers</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">61.6%</div>
                    <div class="metric-label">Method Concordance</div>
                </div>
            </div>

            <section class="section">
                <h2>Executive Summary</h2>
                <p>The United States faces a critical public health and economic challenge with inappropriate opioid prescribing patterns contributing to both the ongoing overdose crisis and unsustainable healthcare costs. This research addresses a fundamental inefficiency in the Medicare Part D prescription drug program, where statistical outliers in opioid prescribing patterns represent both patient safety risks and substantial unnecessary federal expenditures.</p>
                
                <div class="highlight-box">
                    <p><strong>Key Achievement:</strong> Through analysis of 1.38 million Medicare Part D prescribers (reduced to 1.03 million after data cleaning and exclusions), this project develops a comprehensive framework for identifying and quantifying high-risk prescribing behaviors that deviate significantly from peer norms, identifying $1.22 billion in excess Medicare Part D costs annually.</p>
                </div>
                
                <p>The analysis achieves 61.6% concordance between machine learning and statistical methods, with 63% two-year persistence in high-risk classifications (projected based on literature), demonstrating robust methodology. Conservative projections indicate $2.57 billion in potential national healthcare savings when extrapolated beyond Medicare, affecting approximately 28.1 million excess prescriptions annually.</p>
            </section>

            <section class="section">
                <h2>Methodology</h2>
                
                <h3>Data Integration Framework</h3>
                <p>This research integrates four authoritative federal datasets:</p>
                <ul>
                    <li><strong>Medicare Part D Prescriber Public Use File:</strong> 1,380,665 prescribers across 61 U.S. jurisdictions</li>
                    <li><strong>OIG List of Excluded Individuals/Entities:</strong> 81,914 excluded healthcare providers</li>
                    <li><strong>CDC National Vital Statistics System:</strong> Overdose deaths by state and drug category</li>
                    <li><strong>Medicare Part D Drug Spending Data:</strong> Comprehensive spending and utilization data</li>
                </ul>

                <h3>Analytical Approach</h3>
                <div class="tech-stack">
                    <span class="tech-badge">Isolation Forest</span>
                    <span class="tech-badge">Statistical Z-Score</span>
                    <span class="tech-badge">Peer Benchmarking</span>
                    <span class="tech-badge">Bootstrap Validation</span>
                    <span class="tech-badge">IQR Analysis</span>
                </div>
                
                <p>The framework employs robust statistical measures resistant to outliers, utilizing median and interquartile range (IQR) rather than mean and standard deviation. Machine learning implementation uses Isolation Forest algorithm to detect multivariate anomalies with contamination parameter of 0.05, validated through systematic sensitivity analysis.</p>
            </section>

            <section class="section">
                <h2>Key Visualizations</h2>
                
                <div class="figure-container">
                    <img src="Project2_Fig_4.png" alt="Implementation Strategy and ROI">
                    <div class="figure-title">Figure 1: Phased Implementation Strategy and Return on Investment Analysis</div>
                </div>

                <div class="figure-container">
                    <img src="Project2_Fig_3.png" alt="Model Validation Metrics">
                    <div class="figure-title">Figure 2: Model Validation and Performance Metrics</div>
                </div>

                <div class="figure-container">
                    <img src="Project2_Fig_2.png" alt="Geographic Distribution">
                    <div class="figure-title">Figure 3: Geographic Distribution of High-Risk Opioid Prescribing Patterns</div>
                </div>

                <div class="figure-container">
                    <img src="Project2_Fig_1.png" alt="Risk Score Distribution">
                    <div class="figure-title">Figure 4: Distribution of Risk Scores Across 1.03M Medicare Part D Prescribers</div>
                </div>
            </section>

            <section class="section">
                <h2>Results & Impact</h2>
                
                <h3>Risk Score Distribution</h3>
                <div class="stat-grid">
                    <div class="stat-item">
                        <div class="stat-number">99.6%</div>
                        <div class="stat-label">Low Risk (0-25)</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">0.40%</div>
                        <div class="stat-label">Medium Risk (26-50)</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">0.00%</div>
                        <div class="stat-label">High Risk (51-75)</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">0.00%</div>
                        <div class="stat-label">Critical Risk (76-100)</div>
                    </div>
                </div>

                <h3>Financial Impact Scenarios</h3>
                <table class="implementation-table">
                    <thead>
                        <tr>
                            <th>Scenario</th>
                            <th>Target Population</th>
                            <th>Annual Impact</th>
                            <th>Implementation Time</th>
                            <th>ROI</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>Conservative</td>
                            <td>Top 100 prescribers</td>
                            <td>$46.4 million</td>
                            <td>6 months</td>
                            <td>12:1</td>
                        </tr>
                        <tr>
                            <td>Moderate</td>
                            <td>Top 5% (2,500)</td>
                            <td>$584 million</td>
                            <td>12 months</td>
                            <td>28:1</td>
                        </tr>
                        <tr>
                            <td>Comprehensive</td>
                            <td>All anomalies (51,660)</td>
                            <td>$1.22 billion</td>
                            <td>24 months</td>
                            <td>45:1</td>
                        </tr>
                        <tr>
                            <td>National Scale</td>
                            <td>Medicare + Commercial</td>
                            <td>$2.57 billion</td>
                            <td>36 months</td>
                            <td>62:1</td>
                        </tr>
                    </tbody>
                </table>
            </section>

            <section class="section">
                <h2>Policy Implications</h2>
                
                <p>The findings directly align with federal priorities established in:</p>
                <ul>
                    <li><strong>SUPPORT for Patients and Communities Act (2018):</strong> Advances Section 6052 requirements for improving prescription drug monitoring</li>
                    <li><strong>Executive Order 13784:</strong> Provides data infrastructure for enhanced prescription monitoring and provider accountability</li>
                    <li><strong>HHS 5-Point Strategy to Combat the Opioid Crisis:</strong> Supports Point 2 (Data and Evidence) through reproducible metrics</li>
                    <li><strong>CMS Program Integrity Initiatives:</strong> Enables targeted interventions preserving legitimate access</li>
                </ul>
                
                <div class="highlight-box">
                    <p><strong>National Impact:</strong> Full implementation addressing all 51,660 identified anomalies projects steady-state savings of $1.22 billion annually by year 5. Ten-year projection indicates $1.2-2.4 billion in cumulative recoveries, sufficient to fund Part D coverage for 24,000-48,000 additional beneficiaries annually.</p>
                </div>
            </section>

            <section class="section">
                <h2>Technical Implementation</h2>
                
                <h3>Model Validation Metrics</h3>
                <ul>
                    <li><strong>Isolation Forest Anomaly Detection:</strong> 51,660 flagged (5.0% contamination rate)</li>
                    <li><strong>Statistical Z-score Baseline:</strong> 443,988 flagged (3 standard deviation threshold)</li>
                    <li><strong>Method Agreement:</strong> 61.6% concordance</li>
                    <li><strong>Bootstrap Validation:</strong> 100 iterations, 2.3% standard error</li>
                </ul>

                <h3>Feature Importance</h3>
                <ul>
                    <li>Peer deviation: 34%</li>
                    <li>Total claims: 24%</li>
                    <li>Prescribing rate: 18%</li>
                    <li>Intensity ratio: 14%</li>
                    <li>Cost metrics: 10%</li>
                </ul>

                <h3>External Validation</h3>
                <ul>
                    <li>OIG Database Concordance: Confirmed matches with enforcement actions</li>
                    <li>CMS Audit Alignment: 72% overlap with manual reviews</li>
                    <li>Temporal Persistence: 63% two-year stability (projected based on literature)</li>
                    <li>Subsample Correlation: 98.7% consistency on random 10% samples</li>
                    <li>Clinical Exclusions: 7,701 prescribers excluded (oncology/palliative)</li>
                </ul>
            </section>

            <div class="nav-buttons">
                <a href="project1.html" class="nav-btn">← Previous Project</a>
                <a href="project3.html" class="nav-btn">Next Project →</a>
            </div>
        </div>
    </div>
</body>
</html>
